199 related articles for article (PubMed ID: 8738587)
1. Subcutaneous low-molecular-weight heparin versus standard heparin and the prevention of thromboembolism in medical inpatients. The Heparin Study in Internal Medicine Group.
Harenberg J; Roebruck P; Heene DL
Haemostasis; 1996; 26(3):127-39. PubMed ID: 8738587
[TBL] [Abstract][Full Text] [Related]
2. Randomized controlled study of heparin and low molecular weight heparin for prevention of deep-vein thrombosis in medical patients.
Harenberg J; Kallenbach B; Martin U; Dempfle CE; Zimmermann R; Kübler W; Heene DL
Thromb Res; 1990 Aug; 59(3):639-50. PubMed ID: 2173168
[TBL] [Abstract][Full Text] [Related]
3. Prevention of deep vein thrombosis after elective hip surgery. A randomized trial comparing low molecular weight heparin with standard unfractionated heparin.
Levine MN; Hirsh J; Gent M; Turpie AG; Leclerc J; Powers PJ; Jay RM; Neemeh J
Ann Intern Med; 1991 Apr; 114(7):545-51. PubMed ID: 1848054
[TBL] [Abstract][Full Text] [Related]
4. A fixed-dose combination of low molecular weight heparin with dihydroergotamine versus adjusted-dose unfractionated heparin in the prevention of deep-vein thrombosis after total hip replacement.
Horbach T; Wolf H; Michaelis HC; Wagner W; Hoffmann A; Schmidt A; Beck H
Thromb Haemost; 1996 Feb; 75(2):246-50. PubMed ID: 8815569
[TBL] [Abstract][Full Text] [Related]
5. Prevention of deep vein thrombosis with low molecular-weight heparin in patients undergoing total hip replacement. A randomized trial. The German Hip Arthroplasty Trial (GHAT) Group.
Arch Orthop Trauma Surg; 1992; 111(2):110-20. PubMed ID: 1314065
[TBL] [Abstract][Full Text] [Related]
6. Factor Xa inhibition: correlation between the plasma levels of anti-Xa activity and occurrence of thrombosis and haemorrhage.
Leizorovicz A; Bara L; Samama MM; Haugh MC
Haemostasis; 1993 Mar; 23 Suppl 1():89-98. PubMed ID: 8388357
[TBL] [Abstract][Full Text] [Related]
7. A multicenter randomized double-blind study of enoxaparin compared with unfractionated heparin in the prevention of venous thromboembolic disease in elderly in-patients bedridden for an acute medical illness. The Enoxaparin in Medicine Study Group.
Bergmann JF; Neuhart E
Thromb Haemost; 1996 Oct; 76(4):529-34. PubMed ID: 8902991
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and safety of a low-molecular-weight heparin and standard unfractionated heparin for prophylaxis of postoperative venous thromboembolism: European multicenter trial.
Kakkar VV; Boeckl O; Boneu B; Bordenave L; Brehm OA; Brücke P; Coccheri S; Cohen AT; Galland F; Haas S; Jarrige J; Koppenhagen K; LeQuerrec A; Parraguette E; Prandoni P; Roder JD; Roos M; Rüschemeyer C; Siewert JR; Vinazzer H; Wenzel E
World J Surg; 1997 Jan; 21(1):2-8; discussion 8-9. PubMed ID: 8943170
[TBL] [Abstract][Full Text] [Related]
9. Prevention of deep vein thrombosis after hip replacement: randomised comparison between unfractionated heparin and low molecular weight heparin.
Leyvraz PF; Bachmann F; Hoek J; Büller HR; Postel M; Samama M; Vandenbroek MD
BMJ; 1991 Sep; 303(6802):543-8. PubMed ID: 1655136
[TBL] [Abstract][Full Text] [Related]
10. Prevention of deep-vein thrombosis and pulmonary embolism after total hip replacement. Comparison of low-molecular-weight heparin and unfractionated heparin.
Eriksson BI; Kälebo P; Anthymyr BA; Wadenvik H; Tengborn L; Risberg B
J Bone Joint Surg Am; 1991 Apr; 73(4):484-93. PubMed ID: 2013587
[TBL] [Abstract][Full Text] [Related]
11. Comparative effectiveness of unfractionated and low-molecular-weight heparin for prevention of venous thromboembolism following bariatric surgery.
Birkmeyer NJ; Finks JF; Carlin AM; Chengelis DL; Krause KR; Hawasli AA; Genaw JA; English WJ; Schram JL; Birkmeyer JD;
Arch Surg; 2012 Nov; 147(11):994-8. PubMed ID: 23165612
[TBL] [Abstract][Full Text] [Related]
12. Effects of a low-molecular-weight heparin on thrombus regression and recurrent thromboembolism in patients with deep-vein thrombosis.
Breddin HK; Hach-Wunderle V; Nakov R; Kakkar VV;
N Engl J Med; 2001 Mar; 344(9):626-31. PubMed ID: 11228276
[TBL] [Abstract][Full Text] [Related]
13. A double-blind and randomized placebo-controlled trial of low molecular weight heparin once daily to prevent deep-vein thrombosis in acute ischemic stroke.
Sandset PM; Dahl T; Stiris M; Rostad B; Scheel B; Abildgaard U
Semin Thromb Hemost; 1990 Oct; 16 Suppl():25-33. PubMed ID: 1962901
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic application of subcutaneous low-molecular-weight heparin in acute venous thrombosis.
Harenberg J; Huck K; Bratsch H; Stehle G; Dempfle CE; Mall K; Blauth M; Usadel KH; Heene DL
Haemostasis; 1990; 20 Suppl 1():205-19. PubMed ID: 1964663
[TBL] [Abstract][Full Text] [Related]
15. A comparative double-blind, randomised trial of a new second generation LMWH (bemiparin) and UFH in the prevention of post-operative venous thromboembolism. The Bemiparin Assessment group.
Kakkar VV; Howes J; Sharma V; Kadziola Z
Thromb Haemost; 2000 Apr; 83(4):523-9. PubMed ID: 10780310
[TBL] [Abstract][Full Text] [Related]
16. Prevention of thromboembolism with use of recombinant hirudin. Results of a double-blind, multicenter trial comparing the efficacy of desirudin (Revasc) with that of unfractionated heparin in patients having a total hip replacement.
Eriksson BI; Ekman S; Lindbratt S; Baur M; Bach D; Torholm C; Kälebo P; Close P
J Bone Joint Surg Am; 1997 Mar; 79(3):326-33. PubMed ID: 9070519
[TBL] [Abstract][Full Text] [Related]
17. Low molecular weight heparin (KABI 2165) as thromboprophylaxis in elective visceral surgery. A randomized, double-blind study versus unfractionated heparin.
Koller M; Schoch U; Buchmann P; Largiadèr F; von Felten A; Frick PG
Thromb Haemost; 1986 Dec; 56(3):243-6. PubMed ID: 3551180
[TBL] [Abstract][Full Text] [Related]
18. A multicentre study on LMW-heparin effectiveness in preventing postsurgical thrombosis.
Verardi S; Casciani CU; Nicora E; Forzano F; Origone A; Valle I; Catania G; Salanitri G; Salcuni P; Azzarone M
Int Angiol; 1988; 7(3 Suppl):19-24. PubMed ID: 2850322
[TBL] [Abstract][Full Text] [Related]
19. Heparin Study in Internal Medicine (HESIM): design and preliminary results.
Harenberg J; Roebruck P; Stehle G; Habscheid W; Biegholdt M; Heene DL
Thromb Res; 1992 Oct; 68(1):33-43. PubMed ID: 1333105
[TBL] [Abstract][Full Text] [Related]
20. [Prevention of thromboembolism as a cause of thromboembolic complications. A study of the incidence of heparin-induced thrombocytopenia type II].
Ganzer D; Gutezeit A; Mayer G; Greinacher A; Eichler P
Z Orthop Ihre Grenzgeb; 1997; 135(6):543-9. PubMed ID: 9499523
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
